Search: onr:"swepub:oai:DiVA.org:uu-394688" >
Unveiling the Bioch...
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3
-
- Fabini, Edoardo (author)
- Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy;CNR, Natl Res Council, Inst Organ Synth & Photoreact ISOF, Bologna, Italy
-
- Talibov, Vladimir O, 1991- (author)
- Uppsala universitet,Biokemi
-
- Mihalic, Filip (author)
- Uppsala universitet,Institutionen för kemi - BMC
-
show more...
-
- Naldi, Marina (author)
- Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy;St Orsola Marcello Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy
-
- Bartolini, Manuela (author)
- Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy
-
- Bertucci, Carlo (author)
- Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy
-
- Del Rio, Alberto (author)
- CNR, Natl Res Council, Inst Organ Synth & Photoreact ISOF, Bologna, Italy;Innovamol Consulting Srl, Modena, Italy
-
- Danielson, U. Helena, Professor, 1959- (author)
- Uppsala universitet,Biokemi,Science for Life Laboratory, SciLifeLab
-
show less...
-
(creator_code:org_t)
- 2019-08-07
- 2019
- English.
-
In: Biochemistry. - : AMER CHEMICAL SOC. - 0006-2960 .- 1520-4995. ; 58:35, s. 3634-3645
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- SET and MYND domain-containing protein 3 (SMYD3) is a lysine methyltransferase that plays a central role in a variety of cancer diseases, exerting its pro-oncogenic activity by methylation of key proteins, of both nuclear and cytoplasmic nature. However, the role of SMYD3 in the initiation and progression of cancer is not yet fully understood and further biochemical characterization is required to support the discovery of therapeutics targeting this enzyme. We have therefore developed robust protocols for production, handling, and crystallization of SMYD3 and biophysical and biochemical assays for clarification of SMYD3 biochemistry and identification of useful lead compounds. Specifically, a time-resolved biosensor assay was developed for kinetic characterization of SMYD3 interactions. Functional differences in SMYD3 interactions with its natural small molecule ligands SAM and SAH were revealed, with SAM forming a very stable complex. A variety of peptides mimicking putative substrates of SMYD3 were explored in order to expose structural features important for recognition. The interaction between SMYD3 and some peptides was influenced by SAM. A nonradioactive SMYD3 activity assay using liquid chromatography-mass spectrometry (LC-MS) analysis explored substrate features of importance also for methylation. Methylation was notable only toward MAP kinase kinase kinase 2 (MAP3K2_K-260)-mimicking peptides, although binary and tertiary complexes were detected also with other peptides. The analysis supported a random bi-bi mechanistic model for SMYD3 methyltransferase catalysis. Our work unveiled complexities in SMYD3 biochemistry and resulted in procedures suitable for further studies and identification of novel starting points for design of effective and specific leads for this potential oncology target.
Subject headings
- NATURVETENSKAP -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
- NATURAL SCIENCES -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database